Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use Of Hyoscine as An Adjuvant Treatment on Shortening the Time of Abortion Induction in Second Trimester: Randomized Controlled Clinical Trial

NCT06207539 is registered in ClinicalTrials.gov with Ain Shams Maternity Hospital as lead sponsor.

NCT NCT06207539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06207539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use Of Hyoscine as An Adjuvant Treatment on Shortening the Time of Abortion Induction in Second Trimester: Randomized Controlled Clinical Trial
Lead sponsor
Ain Shams Maternity Hospital
Phase
Phase 1
Overall status
Completed
Start date
December 1, 2022
Completion date
April 30, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abortion, second trimester